Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

0 structures for P09250

Entry ID Method Resolution Chain Position Source

4 variants for P09250

Variant ID(s) Position Change Description Diseaes Association Provenance
130 R>Q strain: Isolate 7-1-3 [UniProt] No
154 L>P strain: Isolate 40a2 [UniProt] No
288 S>L strain: Ellen, ppIIa, Isolate clinical GK, Isolate 7-1-3, Isolate 101 and Isolate 3-5-2/KB3 [UniProt] No
319 A>V strain: Isolate clinical GK [UniProt] No

No associated diseases with P09250

No regional properties for P09250

Type Name Position InterPro Accession
No domain, repeats, and functional sites for P09250

Functions

Description
EC Number 2.7.1.21 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
thymidine kinase activity Catalysis of the reaction: ATP + thymidine = ADP + thymidine 5'-phosphate.

3 GO annotations of biological process

Name Definition
DNA biosynthetic process The biosynthetic process resulting in the formation of DNA.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
TMP biosynthetic process The chemical reactions and pathways resulting in the formation of TMP, ribosylthymine monophosphate.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSTDKTDVKM GVLRIYLDGA YGIGKTTAAE EFLHHFAITP NRILLIGEPL SYWRNLAGED
70 80 90 100 110 120
AICGIYGTQT RRLNGDVSPE DAQRLTAHFQ SLFCSPHAIM HAKISALMDT STSDLVQVNK
130 140 150 160 170 180
EPYKIMLSDR HPIASTICFP LSRYLVGDMS PAALPGLLFT LPAEPPGTNL VVCTVSLPSH
190 200 210 220 230 240
LSRVSKRARP GETVNLPFVM VLRNVYIMLI NTIIFLKTNN WHAGWNTLSF CNDVFKQKLQ
250 260 270 280 290 300
KSECIKLREV PGIEDTLFAV LKLPELCGEF GNILPLWAWG METLSNCSRS MSPFVLSLEQ
310 320 330 340
TPQHAAQELK TLLPQMTPAN MSSGAWNILK ELVNAVQDNT S